794 studies found for:
kidney cancer | Open Studies | Exclude Unknown
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
AMG 172 First in Human Study in Patients With Kidney Cancer
|
||||
| 2 | Recruiting |
Autoantibody Blood Test in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
|
||||
| 3 | Recruiting |
Interleukin-2 in Metastatic Kidney Cancer
|
||||
| 4 | Recruiting |
Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
|
||||
| 5 | Recruiting |
Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer
|
||||
| 6 | Recruiting |
Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery
|
||||
| 7 | Recruiting |
A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer
|
||||
| 8 | Not yet recruiting |
Carfilzomib in Refractory Renal Cell Carcinoma (RCC)
|
||||
| 9 | Recruiting |
Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer
|
||||
| 10 | Recruiting |
Phase II Study of Vandetanib in Individuals With Kidney Cancer
|
||||
| 11 | Recruiting |
Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
|
||||
| 12 | Recruiting |
Magnetic Resonance Imaging (MRI) in Predicting Response to Sunitinib Malate in Patients With Locally Advanced or Metastatic Kidney Cancer
|
||||
| 13 | Recruiting |
A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology
|
||||
| 14 | Recruiting |
Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
|
||||
| 15 | Recruiting |
Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
|
||||
| 16 | Not yet recruiting |
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
|
||||
| 17 | Recruiting |
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
|
||||
| 18 | Recruiting |
Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer
|
||||
| 19 | Recruiting |
Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
|
||||
| 20 | Recruiting |
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
|
† Indicates status has not been verified in more than two years
